abstract |
The present invention relates to the prevention or treatment of diseases by regulating innate immunity. The present invention provides a Cbl-family inhibitor for use in the prevention or treatment of diseases in a patient, a Cbl-family inhibitor comprising a binding peptide of Syk, a fusion peptide comprising a cell delivery portion and a Cbl-family TKB domain binding peptide, wherein the Cbl-family TKB domain binding peptide binds to the TKB domain of a Cbl-family protein, kits and uses for the same. |